Table 2.
Utility values derived from the utility valuation survey [37]
| Health State | N | Mean utility value | SD | 95% CI |
| Medication with atomoxetine; responder without side effects | 83 | 0.959 | 0.077 | 0.942 – 0.976 |
| Medication with atomoxetine; responder with side effects | 83 | 0.937 | 0.096 | 0.916 – 0.958 |
| Medication with atomoxetine; non-responder without side effects | 83 | 0.902 | 0.133 | 0.873 – 0.931 |
| Medication with atomoxetine; responder with side effects | 83 | 0.886 | 0.148 | 0.854 – 0.918 |
| Medication with IR-MPH; responder without side effects | 83 | 0.913 | 0.128 | 0.885 – 0.941 |
| Medication with IR-MPH; responder with side effects | 83 | 0.904 | 0.137 | 0.875 – 0.933 |
| Medication with IR-MPH; non-responder without side effects | 83 | 0.889 | 0.154 | 0.856 – 0.922 |
| Medication with IR-MPH; responder with side effects | 83 | 0.875 | 0.164 | 0.840 – 0.910 |
| Medication with XR-MPH; responder without side effects | 83 | 0.930 | 0.107 | 0.907 – 0.953 |
| Medication with XR-MPH; responder with side effects | 83 | 0.912 | 0.124 | 0.885 – 0.939 |
| Medication with XR-MPH; non-responder without side effects | 83 | 0.898 | 0.130 | 0.870 – 0.926 |
| Medication with XR-MPH; responder with side effects | 83 | 0.884 | 0.143 | 0.853 – 0.915 |
| No medication; responder | 23 | 0.880 | 0.133 | 0.826 – 0.934 |
| No medication; non-responder | 23 | 0.880 | 0.133 | 0.826 – 0.934 |
Abbreviations: IR-MPH = immediate-release methylphenidate; XR-MPH = extended-release methylphenidate; SD = standard deviation